Seeking Alpha

Galena Biopharma rallies, SA bull upbeat for 2014

  • Shares of Galena Biopharma (GALE +3.9%) are enjoying a strong session.
  • SA contributor and long-time bull Regarded Solutions is out reiterating a positive outlook for the company going into the new year.
  • "GALE should continue to deliver positive results as they proceed in Phase 3 trials of [their] potential legacy drug, NeuVax," the author says, adding that "sales of Abstral could surprise everyone."
Comments (10)
  • deercreekvols
    , contributor
    Comments (5163) | Send Message
     
    Bought GALE some time back after reading Regarded Solutions and doing some research myself. I have not been disappointed!
    31 Dec 2013, 03:04 PM Reply Like
  • Goattime
    , contributor
    Comments (17) | Send Message
     
    just lost 50 cents after comments!
    31 Dec 2013, 03:09 PM Reply Like
  • heywally
    , contributor
    Comments (178) | Send Message
     
    As far as it dropping 50 cents, as a trading vehicle this stock is great but should be entered with some selectivity and conservative position sizing. Great liquidity right now and an apparently sound fundamental story .... don't forget how much it is up recently.
    31 Dec 2013, 03:15 PM Reply Like
  • Bryce_in_TX
    , contributor
    Comments (2549) | Send Message
     
    Thanks, RS, I got onboard at $3.50.
    31 Dec 2013, 03:15 PM Reply Like
  • paullyons1
    , contributor
    Comments (4) | Send Message
     
    GALE is poised to explode…..deep pipeline too!!….
    31 Dec 2013, 04:49 PM Reply Like
  • JoeMRI
    , contributor
    Comments (18) | Send Message
     
    Bought at 4$ after much research. Love the Canadian PI on Neuvax phase III. Treatment regimen is a big plus-minimizes hospital costs. Phase II data quite strong. Long.
    31 Dec 2013, 05:10 PM Reply Like
  • russleehowe
    , contributor
    Comments (54) | Send Message
     
    I bought 1000 shares 9/30/13. Up 130% since then. Wouldn't even think of selling.
    31 Dec 2013, 05:21 PM Reply Like
  • Brian Nichols
    , contributor
    Comments (2129) | Send Message
     
    It amazes me how quick sentiment has turned since I began covering it two years ago.
    31 Dec 2013, 06:27 PM Reply Like
  • deercreekvols
    , contributor
    Comments (5163) | Send Message
     
    Mr. Nichols,

     

    Could the change in sentiment be something that is seen in the pharmaceutical field regularly, or is GALE the exception to the rule, if there is a rule?

     

    I am truly curious about this. Thanks in advance for any comment.

     

    Happy New Year
    31 Dec 2013, 07:24 PM Reply Like
  • russleehowe
    , contributor
    Comments (54) | Send Message
     
    Bio medical research and knowledge is exploding. There are hundreds, if not thousands, of companies making important discoveries and bringing products to market. Spread your risk over many companies and pray you hit the jackpot (and do your research). The potential gain is far more than the risk, i.e, a $2 stock can only go down $2, but it can go up an infinite amount. For example, JAZZ was less than $1 three years ago and today it's $125. GALE was selling for pennies not long ago and now it's up to $5. Bio tech is the new gold rush. I have personally decided to only invest in bio tech companies. I am up 40% for this month (Dec) alone. 2013 has been wonderful. Let's hope this trend continues. Happy New Year!
    31 Dec 2013, 11:55 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|